22.10.2014 11:12:40
|
Earnings Watch For October 22 (BA, BSX, XRX, CA, ABT, T)
(RTTNews) - Defense and aerospace giant Boeing Co. (BA) is scheduled to post third quarter results before the markets open. The earnings of the company are expected to grow to $1.98 per share from $1.80 per share reported a year earlier, while revenues are anticipated to increase to $23.02 billion from last year's $22.13 billion. The shares of BA closed Tuesday's trade at $127.12. (52-wk H/L $144.57/$116.32)
AT&T, Inc. (T), which recently said it would offer iPad Air 2 with Wi-Fi + Cellular and iPad mini 3 with Wi-Fi + Cellular, is scheduled to report its second quarter results after the close of trading. The Dallas, Texas-based company's earnings are expected to fall to $0.64 per share from the $0.66 per share reported a year earlier. The telecommunications giant is anticipated to report revenues of $33.24 billion, higher than the $32.16 billion reported last year. The stock closed Tuesday at $34.62. (52-wk H/L $37.48/$31.74)
Document technology and business process services provider Xerox Corp. (XRX) is expected to post results for the third quarter. The earnings of the company are projected at $0.26 per share, flat with last year. and revenues are estimated to decline to $5.19 billion from $5.26 billion reported in the previous year. The shares closed Tuesday at $13.20. (52-wk H/L $14.15/$9.55)
Boston Scientific Corp. (BSX) is slated to report third quarter results. The earnings of the medical devices maker are expected to surge to $0.20 per share from $0.10 per share reported a year earlier, while quarterly revenues are anticipated to grow to $1.82 billion from last year's $1.74 billion. The company's shares closed Tuesday's session at $12.03. (52-wk H/L $14.08/$11.10)
Healthcare company Abbott Laboratories (ABT) will report its third-quarter results before the opening bell. The company is expected to post earnings of $0.59 per share, higher than the year-ago quarter's $0.55 per share. Revenues are anticipated to rise to $5.60 billion from $5.37 billion reported a year earlier. The company's shares closed Tuesday's session at $42.39. (52-wk H/L $44.20/$35.65)
Application software solutions provider CA Technologies (CA) is scheduled to post second quarter results after the close of trading. The Islandia, New York-based company is expected to report earnings of $0.62 per share, lower than the $0.85 per share reported a year earlier. Further, revenues are projected to decline to $1.09 billion from $1.14 billion last year. On the Nasdaq, CA closed Tuesday's trade at $27.56. (52-wk H/L $36.22/$25.25)
Biogen Idec (BIIB), Dow Chemical Co (DOW), EMC Corp (EMC), General Dynamics Corp. (GD), Norfolk Southern Corp (NSC), Northrop Grumman Corp. (NOC), Tupperware Brands Corp. (TUP), A. Schulman Inc. (SHLM), Cheesecake Factory Incorporated (CAKE), Citrix Systems Inc (CTXS), Lam Research Corporation (LRCX), Logitech International SA (LOGI), O'Reilly Automotive Inc. (ORLY) and SLM Corp. (SLM) are also due to release their results.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biogen Incmehr Nachrichten
18.11.24 |
NASDAQ Composite Index-Titel Biogen-Aktie: So viel hätte eine Investition in Biogen von vor 3 Jahren gekostet (finanzen.at) | |
14.11.24 |
ROUNDUP: Erste Alzheimer-Therapie in EU zur Zulassung empfohlen (dpa-AFX) | |
14.11.24 |
Erste Alzheimer-Therapie in EU zur Zulassung empfohlen (dpa-AFX) | |
11.11.24 |
NASDAQ Composite Index-Titel Biogen-Aktie: So viel Verlust wäre bei einem Investment in Biogen von vor einem Jahr angefallen (finanzen.at) | |
04.11.24 |
NASDAQ Composite Index-Wert Biogen-Aktie: So viel Verlust hätte ein Biogen-Investment von vor 10 Jahren eingebracht (finanzen.at) | |
29.10.24 |
Ausblick: Biogen mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
28.10.24 |
NASDAQ Composite Index-Wert Biogen-Aktie: So viel Verlust hätte ein Investment in Biogen von vor 5 Jahren eingebracht (finanzen.at) | |
21.10.24 |
Montagshandel in New York: NASDAQ 100 schließt in der Gewinnzone (finanzen.at) |
Analysen zu Biogen Incmehr Analysen
Aktien in diesem Artikel
Abbott Laboratories | 110,44 | 0,15% | |
AT&T Inc. (AT & T Inc.) | 21,75 | 1,26% | |
Biogen Inc | 147,65 | -0,03% | |
Boeing Co. | 138,30 | 1,02% | |
Boston Scientific Corp. | 85,50 | -0,58% | |
General Dynamics Corp. | 266,90 | -1,84% | |
Lam Research Corp. | 720,00 | -0,54% | |
Norfolk Southern Corp. | 244,00 | -0,81% | |
Northrop Grumman Corp. | 467,60 | 1,10% | |
SLM Corp. | 22,40 | -0,88% | |
The Cheesecake Factory Inc. | 44,00 | -0,45% | |
Tupperware Corp. | 0,20 | 21,21% |